Videos
Femtech in the Spotlight — An Interview with Wolfgang Hackl — Founder and CEO of OncoGenomX
July 11, 2022
Eva von Mühlenen (Advisor, Geneva) and Josefine Sommer (Senior Managing Associate, Brussels) interviewed Wolfgang Hackl, founder of OncoGenomX, a Femtech startup that guides doctors in the treatment of breast cancer — about regulation, research and development (R&D), and the vast potential of artificial intelligence in the field of health technology for women.
Contacts
Related Resources
Related Blogs
Capabilities
Related Pages
Suggested News & Insights
Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026Swiss MedTech 2026Tuesday, August 25, 2026When AI Changes the Deal: Rethinking Risk, Milestones, and Timing in Life Sciences M&AJuly 29, 2026The Evolving Global Landscape for Orphan Drug ExclusivityJuly 28, 2026Bay Area Life Sciences RoundtableWednesday, July 22, 2026Sidley Wins Summary Judgment for Chemo Research, S.L. in Trade Secret and Unfair Competition CaseJuly 20, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory